CICR Steering Committee

Vice-President
Molecular Innovation
Indiana Biosciences Research Institute
Indianapolis, Indiana

Principal Scientist
Discovery Chemistry
Genentech, Inc.
South San Francisco, California

Head, Therapeutic Innovation and Drug Discovery
Ontario Institute for Cancer Research
Toronto, Canada

Professor, Pharmaceutical Chemistry, School of Pharmacy
University of California San Francisco
San Francisco, California 

Associate Professor
Cancer Biology, Dana-Farber Cancer Institute
Biological Chemistry and Molecular Pharmacology
Harvard Medical School
Boston, Massachusetts

Vice-President
Protein Degrader Platform
Foghorn Therapeutics
Cambridge, Massachusetts

Director
Bristol Myers Squibb
Cambridge, Massachusetts

George P. Canellos, MD, and Jean S. Canellos Professor of Medicine
Harvard Medical School;
Chair of Medical Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

Vice President, Medicinal Chemistry
Revolution Medicines
Redwood City, California

Director and Head of Medicinal Chemistry GER
Merck Healthcare KGaA
Darmstadt, Germany

Vice President, Head of Chemistry
Foghorn Therapeutics
Cambridge, Massachusetts 

Vice President, Chemistry
C4 Therapeutics
Watertown, Massachusetts

Professor of Chemical Biology
Department of Chemistry
University of California, Berkeley

Founder and Chief Innovation Officer
Arrakis Therapeutics
Waltham, Massachusetts

Director, CBT Chemistry Centers
St. Jude Children’s Research Hospital
Memphis, Tennessee

Head of China Innovation Center of Roche
Senior Vice President
Shanghai, China